Global /China /Healthcare /Drug Manufacturers - General /000989

Jiuzhitang Co., Ltd.

000989

• SHE: 000989 • Delayed

9.65CNY -0.9%

1.43 USD

As of 14 June 2026, Jiuzhitang Co., Ltd. has a market cap of $1.22B USD, ranking #9605 globally and #2606 in China. It ranks #832 in the Healthcare sector, and #314 in the Drug Manufacturers - General industry.

Global Rank

9605

Country Rank

2606

Sector Rank

832

Industry Rank

314

Key Stats

Market Cap

$1.22BUSD

8.24B CNY

Enterprise Value

$1.15BUSD

7.81B CNY

Revenue (TTM)

$328.99MUSD

2.23B CNY

EBITDA (TTM)

$53.91MUSD

364.86M CNY

Net Income (TTM)

$32.85MUSD

222.6M CNY

EBITDA Margin

16%

Profit Margin

10%

PE Ratio

37.0

PS Ratio

3.7

PB Ratio

2.0

EV/EBITDA

21.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Li Zhen Guo open_in_new

Employees

3,674

Founded

1999

Website

hnjzt.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.9%	-2.2%	2.9%	9.3%	-3%	11%	8.1%	-26%	14%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000989 九芝堂股份有限公司 Class A ISIN: CNE000001394 Shares Out.: Shares Outstanding: 846.282M¹ Shares Float: 639.481M² TV: TradingView: SZSE: 000989 SA: Stock Analysis: SHE: 000989 YF: Yahoo Finance: 000989.SZ GF: Google Finance: SHE: 000989 BA: Barron's: 000989 MS: Morningstar: XSHE: 000989	9.65 CNY	TV: TradingView: SZSE: 000989 SA: Stock Analysis: SHE: 000989 YF: Yahoo Finance: 000989.SZ GF: Google Finance: SHE: 000989 BA: Barron's: 000989 MS: Morningstar: XSHE: 000989

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jiuzhitang Co., Ltd.

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaxi Ganxian granules, and Chidan Tuihuang granules for liver diseases. The company also provides over-the-counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products, and stem cell and other drugs. Jiuzhitang Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 63K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 45K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 30K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 26K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 24K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 22K%	20.5	Switzerland

chevron_leftBack